ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,020, issued on Sept. 22, was assigned to Exuma Biotech Corp. (West Palm Beach, Fla.) and BioAtla Inc. (San Diego).
"Chimeric antigen receptors to HER2 and methods of use thereof" was invented by Gregory Ian Frost (West Palm Beach, Fla.), James Joseph Onuffer Jr. (Alameda, Calif.), Anirban Kundu (Georgetown, Cayman Islands), Jay M. Short (Jackson, Wyo.), Gerhard Frey (San Diego) and Hwai Wen Chang (San Marcos, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides chimeric antigen receptors (CARs), and nucleic acids comprising nucleotide sequences encoding the CARs, that bind to HER2, and conditionally active biologic ...